Efficacy and safety of inhaled formoterol in Japanese COPD patients with %FEV1>=80%
- Conditions
- Japanese COPD patients with %FEV1>=80%
- Registration Number
- JPRN-UMIN000019118
- Lead Sponsor
- Kanazawa University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 30
Not provided
Key exclusion criteria ware: a history or current clinical diagnosis of asthma or atopic disease such as allergic rhinitis; positive to specific IgE for environmental allergens; positive results of a methacholine inhalation challenge (<10,000 micro g/ml); use of long acting beta2-aganist, long acting muscarinic antagonist, theophylline, inhaled/oral/intravenous steroid, leukotriene receptor antagonist; sensitivity to the study drug; poor inhalation technique of the study drug; exhaled nitric oxide over 22 ppb in ex smoker or 18 ppb in current smoker (NIOX MINO); respiratory infection or respiratory tract disorder other than COPD; unstable ischemic heart disease or any other relevant cardiovascular disorder; women of childbearing potential or of breast-feeding; mental disorder or psychiatric symptom; several medical conditions prohibiting partitipation
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method